Status:
COMPLETED
Cognitive Adaptive Training for Improving Medication Adherence, Symptoms, and Function in People With Schizophrenia
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Schizophrenia
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
This study will compare the effectiveness of three treatments in improving medication adherence, symptoms, and function in people with schizophrenia.
Detailed Description
Schizophrenia is a chronic and severely disabling mental disorder. People with schizophrenia may experience hallucinations, delusions, disordered thinking, movement disorders, social withdrawal, and c...
Eligibility Criteria
Inclusion
- Diagnosis of schizophrenia or schizoaffective disorder
- If entering the study as an inpatient, hospitalization was recent
- Currently receiving treatment with an atypical antipsychotic and continuation on the medication has been recommended
- Assumes primary responsibility for taking medication
- Currently living in a stable environment
Exclusion
- History of significant head trauma, seizure disorder, or mental retardation
- History of alcohol or drug abuse or dependence within 1 month prior to study entry
- History of violence within 6 months prior to study entry
Key Trial Info
Start Date :
November 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2006
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT00455663
Start Date
November 1 2000
End Date
January 1 2006
Last Update
June 15 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Health Science Center
San Antonio, Texas, United States, 78229-3900